Pharma
Global Immunoassays in R&D Market Opportunities and Forecast 2020-2027
  • DLR2167
  • 20 August, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Immunoassays in R&D Market, By Product & Service (Kits and Reagents, Analyzers, Software and Services), By Application (Infectious Diseases, Cancer Research, Endocrinology, Autoimmune Diseases, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions and Laboratories, Others), and opportunities and forecast 2020-2027

Immunoassays in R&D Market Overview

Immunoassays are bioanalytical procedures in which the analyte's quantification is based on the reaction of an antigen (analyte) and an antibody. Immunoassays are widely utilized in pharmaceutical analysis, including illness diagnostics, therapeutic medication monitoring, clinical pharmacokinetics, and bioequivalence studies in drug development.

The major drivers propelling market expansion include factors such as the rising incidence rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advances.

On the other hand, the high cost of immunoassay procedures and the high cost of immunoassay systems limit the global market's growth.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Product & Service, Application, End User, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Becton, Dickinson and Company, Danaher Corporation, bioMérieux Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corporation, and Abcam plc.


Covid-19 Impact on Immunoassays in R&D Market
 
In addition, the current Immunoassays in R&D Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Immunoassays in R&D Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Immunoassays in R&D Market Segment Overview



According to Product & Service, the Kits and Reagents is one of the most prominent segments of the global Immunoassays in R&D Market.  A reagent is an integral part of any chemical reaction. A reagent is a substance or compound that can facilitate a reaction, and they are used in the most widely used tests. This includes, for example, pregnancy tests, blood glucose tests, and most COVID-19 test kits.

Immunoassays in R&D Market, By Product & Service
·       Kits and Reagents
·       Analyzers
·       Software and Services
 
Immunoassays in R&D Market, By Application
·       Infectious Diseases
·       Cancer Research
·       Endocrinology
·       Autoimmune Diseases
·       Others

Immunoassays in R&D Market, By End User
·       Pharmaceutical and Biotechnology Companies
·       Academic Institutions and Laboratories
·       Others

Immunoassays in R&D Regional Overview

The global Immunoassays in R&D market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the immunoassay in R&D market during the projected period. This is due to an increase in the number of research projects in laboratories, as research laboratories are critical to the regional market's growth. Government agencies also award a number of research grants. During the estimated period, the European market for immunoassays in R&D is predicted to be the second-largest. The regional market is likely to develop as their use in diagnostic measures increases. Asia-Pacific is expected to be the fastest-growing market. This is due to improved healthcare infrastructure and rising disposable income. The number of research activities in the region has expanded as the healthcare infrastructure has improved. Other factors likely to enhance regional market growth include an increase in the number of research and development centers and a focus on strategic collaborations by companies operating in the market.

Immunoassays in R&D Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Immunoassays in R&D Market Competitor overview

Some key developments and strategies adopted by manufacturers in Anti-Reflective Coatings are highlighted below.

·       In May 2018, Bio-Rad Laboratories Inc. announced the launch of StarBright Blue 520 Fluorescent Secondary Antibodies, fluorescent dye-labeled secondary antibodies for use in multiplex western blotting. They exhibit a two- to the threefold lower limit of detection than traditional green emission fluorophore-labeled antibodies such as Alexa Fluor 488 or DyLight 488, the current industry standards.

Immunoassays in R&D Market, Key Players

·       Bio-Rad Laboratories, Inc.
·       Thermo Fisher Scientific Inc.
·       Siemens Healthineers
·       Becton
·       Dickinson and Company
·       Danaher Corporation
·       bioMérieux Inc.
·       Abbott Laboratories
·       F. Hoffmann-La Roche Ltd
·       Sysmex Corporation
·       Abcam plc.

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the global Immunoassays in R&D market?

A. The major drivers propelling market expansion include factors such as the rising incidence rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advances

Q2. What are the restraining factors for the global Immunoassays in R&D market?

A. The high cost of immunoassay procedures and the high cost of immunoassay systems limit the global market's growth

Q3. Which segment is projected to hold the largest share in the global Immunoassays in R&D market?

A. Kits and Reagents segment is projected to hold the largest share in the global Immunoassays in R&D market.

Q4. Which region holds the largest share in the global Immunoassays in R&D market?

A. North America holds the largest share in the global Immunoassays in R&D market

Q5. Which are the prominent players in the global Immunoassays in R&D market?

A. Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Becton, Dickinson and Company, Danaher Corporation, bioMérieux Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sysmex Corporation, and Abcam plc. are some key players in the global Immunoassays in R&D market
Immunoassays in R&D Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product & Service
        • 5.2.1. Kits and Reagents
        • 5.2.2. Analyzers
        • 5.2.3. Software and Services
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Infectious Diseases
        • 5.3.2. Cancer Research
        • 5.3.3. Endocrinology
        • 5.3.4. Autoimmune Diseases
        • 5.3.5. Others
      • 5.4. Market Analysis, Insights and Forecast – By End User
        • 5.4.1. Pharmaceutical and Biotechnology Companies
        • 5.4.2. Academic Institutions and Laboratories
        • 5.4.3. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product & Service
        • 6.2.1. Kits and Reagents
        • 6.2.2. Analyzers
        • 6.2.3. Software and Services
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Infectious Diseases
        • 6.3.2. Cancer Research
        • 6.3.3. Endocrinology
        • 6.3.4. Autoimmune Diseases
        • 6.3.5. Others
      • 6.4. Market Analysis, Insights and Forecast – By End User
        • 6.4.1. Pharmaceutical and Biotechnology Companies
        • 6.4.2. Academic Institutions and Laboratories
        • 6.4.3. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product & Service
        • 7.2.1. Kits and Reagents
        • 7.2.2. Analyzers
        • 7.2.3. Software and Services
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Infectious Diseases
        • 7.3.2. Cancer Research
        • 7.3.3. Endocrinology
        • 7.3.4. Autoimmune Diseases
        • 7.3.5. Others
      • 7.4. Market Analysis, Insights and Forecast – By End User
        • 7.4.1. Pharmaceutical and Biotechnology Companies
        • 7.4.2. Academic Institutions and Laboratories
        • 7.4.3. Others
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product & Service
        • 8.2.1. Kits and Reagents
        • 8.2.2. Analyzers
        • 8.2.3. Software and Services
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Infectious Diseases
        • 8.3.2. Cancer Research
        • 8.3.3. Endocrinology
        • 8.3.4. Autoimmune Diseases
        • 8.3.5. Others
      • 8.4. Market Analysis, Insights and Forecast – By End User
        • 8.4.1. Pharmaceutical and Biotechnology Companies
        • 8.4.2. Academic Institutions and Laboratories
        • 8.4.3. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Immunoassays in R&D Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product & Service
        • 9.2.1. Kits and Reagents
        • 9.2.2. Analyzers
        • 9.2.3. Software and Services
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Infectious Diseases
        • 9.3.2. Cancer Research
        • 9.3.3. Endocrinology
        • 9.3.4. Autoimmune Diseases
        • 9.3.5. Others
      • 9.4. Market Analysis, Insights and Forecast – By End User
        • 9.4.1. Pharmaceutical and Biotechnology Companies
        • 9.4.2. Academic Institutions and Laboratories
        • 9.4.3. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Bio-Rad Laboratories, Inc.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Thermo Fisher Scientific Inc.
      • 10.6. Siemens Healthineers
      • 10.7. Becton
      • 10.8. Dickinson and Company
      • 10.9. Danaher Corporation
      • 10.10. bioMérieux Inc.
      • 10.11. Abbott Laboratories
      • 10.12. F. Hoffmann-La Roche Ltd
      • 10.13. Sysmex Corporation
      List of Figures

      Figure 1: Global Immunoassay in R&D Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Immunoassay in R&D Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Immunoassay in R&D Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Immunoassay in R&D Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Immunoassay in R&D Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Immunoassay in R&D Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Immunoassay in R&D Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Immunoassay in R&D Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Immunoassay in R&D Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Immunoassay in R&D Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Immunoassay in R&D Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Immunoassay in R&D Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Immunoassay in R&D Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934